CRIS
NASDAQ
$4.52
Curis Inc (CRIS)
Curis, Inc., a biotechnology company, is dedicated to the discovery and development of drug candidates for the treatment of human cancers in the United States. The company is headquartered in Lexington, Massachusetts.
Sector:
Healthcare
Industry:
Biotechnology
Strong Buy
Target: $280 (+6094.69%)
Market Cap
$9.45M
P/B Ratio
0.71
Beta (5Y)
1.62
Price Chart
Valuation
Market Cap$9.45M
P/S1.30
P/B0.71
Profitability
Total Revenue (TTM)$7.06M
Gross Profit (TTM)-$19M
EBITDA-$6.96M
Profit Margin-299.7%
Operating Margin-485.1%
EPS-$10.35
Growth & Risk
EPS 5Y CAGR-31.57%
Revenue 5Y CAGR-7.29%
FCF 5Y CAGR+0.59%
Beta (5Y)1.62
Sharpe Ratio-1.26